Collegium Pharmaceutical (COLL) announced that Vikram Karnani has been appointed as president and CEO of Collegium and will join its board of directors effective November 12. Michael Heffernan, who has served as interim president and CEO since May, will remain chairman of the board. Vikram Karnani most recently served as EVP and president, global commercial operations and medical affairs at Amgen (AMGN).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL: